» Articles » PMID: 8762605

The Pathogenesis of Chronic Obstructive Pulmonary Disease of Horses

Overview
Journal Br Vet J
Date 1995 May 1
PMID 8762605
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Present evidence suggests that chronic obstructive pulmonary disease (COPD) of horses is a delayed hypersensitivity response to inhaled antigens, particularly the thermophilic moulds and actinomycetes that grow in damp hay. Within several hours of exposing COPD-susceptible horses to such hay, neutrophils invade the lung and accumulate in the lumens of airways, particularly bronchioles. The inflammatory response is accompanied by increased levels of histamine in bronchoalveolar lavage fluid, increased plasma levels of the inflammatory mediators thromboxane and 15-hydroxyeicosatetraenoic acid (15-HETE), and a decrease in the production of prostaglandin (PG) E2 by the airway mucosa. During acute exacerbations of COPD, airways exhibit nonspecific hyperresponsiveness and become obstructed as a result of bronchospasm and the accumulation of mucus and exudates. Bronchospasm is due largely to activation of smooth muscle muscarinic receptors by acetylcholine (ACh). Because the in vitro response of smooth muscle to ACh is unaltered, the increase in airway smooth muscle tone is probably a result of activation of airway reflexes by inflammatory mediators and decreases in inhibitory mechanisms such as the intrapulmonary nonadrenergic noncholinergic nervous system and the production of PGE2 in affected horses. The diffuse airway obstruction leads to uneven distribution of ventilation, ventilation/perfusion mismatching, and hypoxaemia. As a result of the increased respiratory drive caused by hypoxaemia and the presence of airway obstruction, horses adopt a characteristic breathing strategy in which very high peak flows at the start of exhalation rapidly diminish as exhalation proceeds.

Citing Articles

Comparative study of the bronchodilator efficacy and adverse effects of salbutamol and hyoscine butylbromide in horses with severe asthma.

Vives B, Mainguy-Seers S, Lavoie J J Vet Intern Med. 2024; 38(3):1835-1841.

PMID: 38609079 PMC: 11099713. DOI: 10.1111/jvim.17057.


Immunoproteomics enable broad identification of new antigens in severe equine asthma.

Jentsch M, Lubke S, Schrodl W, Volke D, Krizsan A, Hoffmann R Front Immunol. 2024; 15:1347164.

PMID: 38487534 PMC: 10937411. DOI: 10.3389/fimmu.2024.1347164.


Decision Making in Severe Equine Asthma-Diagnosis and Monitoring.

Simoes J, Tilley P Animals (Basel). 2023; 13(24).

PMID: 38136909 PMC: 10740644. DOI: 10.3390/ani13243872.


A Longitudinal Analysis of Equine Asthma Presentation and Response to Treatment Using Lung Function Testing and BAL Cytology Analysis in Combination with Owner Perception.

Robins T, Bedenice D, Mazan M Animals (Basel). 2023; 13(21).

PMID: 37958142 PMC: 10649418. DOI: 10.3390/ani13213387.


Airway Hyperresponsiveness, but Not Bronchoalveolar Inflammatory Cytokines Profiles, Is Modified at the Subclinical Onset of Severe Equine Asthma.

Frippiat T, Art T, Tosi I Animals (Basel). 2023; 13(15).

PMID: 37570294 PMC: 10417247. DOI: 10.3390/ani13152485.